Prelims Pinpointer for 26-June-2025

Syllabus: GS1 – History

Key Points:

Location: Anantapadmanabha Temple, Perduru, Udupi district, Karnataka.

Significance: The lamp contains Shaiva and Vaishnavaite sculptures, making it a rare syncretic artifact.

Date: Donated in 1456 A.D. as per stone inscription.

Shaiva Depiction: Lord Shiva as Nataraja performing Pralaya Tandava, accompanied by Parvati, Ganapati, Bringi, Khadga Ravana, Kumara.

Vaishnava Depiction: Brahma, Indra, Agni, Varuna, and Anantapadmanabha calming Shiva’s dance.

Cultural Highlight: Khadga Ravana seated on Goddess Mari, a locally revered deity.

Syllabus: GS1 – Geography & Environmental Science

Key Points:

Definition: Spreading finely crushed rocks (like basalt) on soil to accelerate natural weathering and capture COâ‚‚.

Process Output: Converts COâ‚‚ into bicarbonate and limestone.

Additional Benefits: Improves soil health, reduces acidic runoff.

Risks: Possible toxic heavy metals, incorrect carbon capture estimates leading to over-crediting.Current Scope: Projects in India, Brazil, USA gaining investor interest.

Syllabus: GS2 – Governance

Key Points:

Established: In 1921, post Montagu-Chelmsford Reforms.

Members: 22 total (15 LS + 7 RS), elected by proportional representation. No ministers allowed.

Chairperson: Appointed by Speaker of Lok Sabha.

Role: Examines CAG audit reports, ensures Parliament-approved funds are used correctly.

Recent Issue: Criticized CGHS for ignoring outdated drug procurement policies.

Syllabus: GS2 – Governance / Welfare Schemes

Key Points:

Organisation: EPFO (under Ministry of Labour & Employment).

Change: Auto-settlement limit increased from ₹1 lakh to ₹5 lakh.

Purpose: To facilitate quicker disbursal of EPF funds for medical, marriage, housing, education.

Context: Auto-settlement introduced during Covid-19.

Syllabus: GS2 – Health

Key Points:

Pathogen Type: Fungal infection; high mortality (55–60%).

Resistance: Gained resistance to fluconazole and voriconazole.

Treatment Category: Belongs to azole antifungals.

Concern: Rise in drug-resistant fungal infections.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top